Daiichi Sankyo Announces Decision to Develop Vaccine in Japan for Novel Corona Virus Infection (COVID-19) Read more
Grifols starts production of its hyperimmune immunoglobulin as a potential passive immune therapy against COVID-19 Read more
European Commission approves Sarclisa for adults with relapsed and refractory multiple myeloma Read more
Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia Read more